Therefore, YY1 inhibition could be considered as a potential tumor therapeutic strategy to give consistent clinical outcomesYY1 is associated with HIF-1 α regulation under hypoxia, and targeting YY1 might be a potential therapeutic strategy of solid cancer [47]. This evidence concerns the gene YY1 and neoplasm.